๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Methylphenidate hydrochloride - Medicines in Ireland

24 authorised products containing Methylphenidate hydrochloride, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 24 authorised medicines
MedicineActive substanceLicence holderStatus
Concerta XL 18 mg prolonged-release tablets
PA22612/002/001
Methylphenidate hydrochloride, Methylphenidate hydrochloride, Methylphenidate hydrochloride Janssen Sciences Ireland Unlimited Company Marketed
Concerta XL 27 mg prolonged-release tablets
PA22612/002/004
Methylphenidate hydrochloride Janssen Sciences Ireland Unlimited Company Marketed
Concerta XL 36 mg prolonged-release tablets
PA22612/002/002
Methylphenidate hydrochloride, Methylphenidate hydrochloride, Methylphenidate hydrochloride Janssen Sciences Ireland Unlimited Company Marketed
Equasym XL 10 mg modified-release capsules, hard
PA23211/001/001
Methylphenidate hydrochloride Takeda Pharmaceuticals International AG Ireland Branch Marketed
Equasym XL 20 mg modified-release capsules, hard
PA23211/001/002
Methylphenidate hydrochloride Takeda Pharmaceuticals International AG Ireland Branch Marketed
Equasym XL 30 mg modified-release capsules, hard
PA23211/001/003
Methylphenidate hydrochloride Takeda Pharmaceuticals International AG Ireland Branch Marketed
Equasym XL 40 mg modified-release capsules, hard
PA23211/001/004
Methylphenidate hydrochloride Takeda Pharmaceuticals International AG Ireland Branch Not marketed
Equasym XL 50 mg modified-release capsules, hard
PA23211/001/005
Methylphenidate hydrochloride Takeda Pharmaceuticals International AG Ireland Branch Not marketed
Equasym XL 60 mg modified-release capsules, hard
PA23211/001/006
Methylphenidate hydrochloride Takeda Pharmaceuticals International AG Ireland Branch Not marketed
Medikinet 10 mg tablets
PA1555/001/007
Methylphenidate hydrochloride Medice Arzneimittel Putter GmbH & Co. K.G Marketed
Medikinet 20 mg tablets
PA1555/001/008
Methylphenidate hydrochloride Medice Arzneimittel Putter GmbH & Co. K.G Marketed
Medikinet 5 mg tablets
PA1555/001/006
Methylphenidate hydrochloride Medice Arzneimittel Putter GmbH & Co. K.G Marketed
Medikinet MR 10mg modified โ€“ release capsules, hard
PA1555/001/002
Methylphenidate hydrochloride, Methylphenidate hydrochloride Medice Arzneimittel Putter GmbH & Co. K.G Marketed
Medikinet MR 20mg modified โ€“ release capsules, hard
PA1555/001/003
Methylphenidate hydrochloride, Methylphenidate hydrochloride Medice Arzneimittel Putter GmbH & Co. K.G Marketed
Medikinet MR 30mg modified โ€“ release capsules, hard
PA1555/001/004
Methylphenidate hydrochloride Medice Arzneimittel Putter GmbH & Co. K.G Marketed
Medikinet MR 40mg modified โ€“ release capsules, hard
PA1555/001/005
Methylphenidate hydrochloride, Methylphenidate hydrochloride Medice Arzneimittel Putter GmbH & Co. K.G Marketed
Medikinet MR 5mg modified โ€“ release capsules, hard
PA1555/001/001
Methylphenidate hydrochloride, Methylphenidate hydrochloride Medice Arzneimittel Putter GmbH & Co. K.G Marketed
Ritalin 10mg Tablets
PA1972/002/001
Methylphenidate hydrochloride InfectoPharm Arzneimittel und Consilium GmbH Marketed
Ritalin LA 20mg prolonged-release capsules
PA1972/002/002
Methylphenidate hydrochloride InfectoPharm Arzneimittel und Consilium GmbH Marketed
Ritalin LA 30mg prolonged-release capsules
PA1972/002/003
Methylphenidate hydrochloride InfectoPharm Arzneimittel und Consilium GmbH Marketed
Ritalin LA 40mg prolonged-release capsules
PA1972/002/004
Methylphenidate hydrochloride InfectoPharm Arzneimittel und Consilium GmbH Marketed
Tuzulby 20 mg prolonged-release chewable tablets
EU/1/24/1907/001
Methylphenidate hydrochloride Laboratorios Lesvi, S.L. โ€”
Tuzulby 30 mg prolonged-release chewable tablets
EU/1/24/1907/002
Methylphenidate hydrochloride Laboratorios Lesvi, S.L. โ€”
Tuzulby 40 mg prolonged-release chewable tablets
EU/1/24/1907/003
Methylphenidate hydrochloride Laboratorios Lesvi, S.L. โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.